Discovery and Optimization of Novel Small-Molecule Inhibitors and Modulators
This special issue belongs to the section "Medicinal Chemistry".
Special Issue Information
Dear Colleagues,
The discovery and development of novel small-molecule inhibitors and modulators is emerging as a highly important topic in modern medicinal chemistry and pharmaceutical research. Small molecules that selectively modulate enzymes, receptors, ion channels, signalling proteins and other therapeutically relevant targets offer key opportunities to elucidate disease mechanisms and develop new treatment strategies. Recent advances in pharmacology, structural biology, computational drug design, virtual screening and chemical synthesis have significantly accelerated the identification and optimisation of bioactive small molecules with improved potency, selectivity and drug-like properties.
However, the discovery of clinically promising compounds remains challenging and requires in-depth evaluation of structure–activity relationships (SAR), optimisation of physicochemical and pharmacokinetic properties and elucidation of mechanisms of action. The design of novel chemical scaffolds and the optimisation of lead compounds therefore remain a crucial area of research in drug discovery.
This Special Issue, “Discovery and Optimization of Novel Small-Molecule Inhibitors and Modulators”, welcomes original research and review articles covering the design, synthesis, molecular modelling, screening, SAR studies and biological and pharmacological evaluation of novel small-molecule inhibitors, receptor agonists and receptor antagonists. Contributions addressing innovative therapeutic targets, emerging drug-design strategies, mechanism-of-action studies and promising lead compounds for pharmaceutical development are particularly encouraged.
Dr. Matej Sova
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small-molecule inhibitors
- agonists
- antagonists
- modulators
- medicinal chemistry
- drug discovery
- computational design and modelling
- structure-activity relationships
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

